MR
Marizyme, Inc.
MRZM · OTC
$0.00 +0.00% (+$0.00)
Market Cap $39.5K
P/E Ratio -
Div. Yield -
ROE -
Analiza
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.06x
P/E N/A
EV/EBITDA N/A
Growth
100 /100
Growing Rev. growth 48.52%
EPS growth N/A
FCF growth N/A
Profitability
14 /100
Weak Gross margin 36.99%
Net margin 10,767.80%
FCF margin 725.42%
Quality
0 /100
Poor ROIC 186.37%
ROA 315.87%
Asset turnover 0.03x
Debt
0 /100
High Current ratio 0.04x
Int. coverage -1.86x
Debt/Equity N/A
Stability
26 /100
Unstable Beta 0.86x
Rev. volatility 96.87%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o MRZM
Online
Sector
Healthcare
Industry
Biotechnology
CEO
David L. Barthel
Employees
13
Headquarters
Jupiter